These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35995589)

  • 1. Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease.
    Billette OV; Ziegler G; Aruci M; Schütze H; Kizilirmak JM; Richter A; Altenstein S; Bartels C; Brosseron F; Cardenas-Blanco A; Dahmen P; Dechent P; Dobisch L; Fliessbach K; Freiesleben SD; Glanz W; Göerß D; Haynes JD; Heneka MT; Kilimann I; Kimmich O; Kleineidam L; Laske C; Lohse A; Rostamzadeh A; Metzger C; Munk MH; Peters O; Preis L; Priller J; Scheffler K; Schneider A; Spottke A; Spruth EJ; Ramirez A; Röske S; Roy N; Teipel S; Wagner M; Wiltfang J; Wolfsgruber S; Yakupov R; Zeidman P; Jessen F; Schott BH; Düzel E; Maass A;
    Neurology; 2022 Aug; 99(8):e775-e788. PubMed ID: 35995589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status.
    Li S; Daamen M; Scheef L; Gaertner FC; Buchert R; Buchmann M; Buerger K; Catak C; Dobisch L; Drzezga A; Ertl-Wagner B; Essler M; Fliessbach K; Haynes JD; Incesoy EI; Kilimann I; Krause BJ; Lange C; Laske C; Priller J; Ramirez A; Reimold M; Rominger A; Roy N; Scheffler K; Maurer A; Schneider A; Spottke A; Spruth EJ; Teipel SJ; Tscheuschler M; Wagner M; Wolfsgruber S; Düzel E; Jessen F; Peters O; Boecker H;
    J Alzheimers Dis; 2021; 79(2):493-509. PubMed ID: 33337359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
    Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
    Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
    Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
    J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Cerebral Blood Flow in the Posterior Cingulate and Precuneus and the Entorhinal Cortical Atrophy Score Differentiate Mild Cognitive Impairment and Dementia Due to Alzheimer Disease.
    Thomas B; Sheelakumari R; Kannath S; Sarma S; Menon RN
    AJNR Am J Neuroradiol; 2019 Oct; 40(10):1658-1664. PubMed ID: 31515217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
    Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
    Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease.
    Green ZD; Vidoni ED; Swerdlow RH; Burns JM; Morris JK; Honea RA
    J Alzheimers Dis; 2023; 91(2):559-571. PubMed ID: 36463439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity in Memory Brain Networks During Encoding Differentiates Mild Cognitive Impairment Converters from Non-Converters.
    Aguirre N; Costumero V; Marin-Marin L; Escudero J; Belloch V; Parcet MA; Ávila C
    J Alzheimers Dis; 2019; 71(3):1049-1061. PubMed ID: 31476154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2.
    Yildirim Z; Delen F; Berron D; Baumeister H; Ziegler G; Schütze H; Glanz W; Dobisch L; Peters O; Freiesleben SD; Schneider LS; Priller J; Spruth EJ; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Meiberth D; Buerger K; Janowitz D; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Laske C; Munk MH; Spottke A; Roy N; Heneka M; Brosseron F; Wagner M; Roeske S; Ramirez A; Ewers M; Dechent P; Hetzer S; Scheffler K; Kleineidam L; Wolfsgruber S; Yakupov R; Schmid M; Berger M; Gurvit H; Jessen F; Duzel E
    Alzheimers Res Ther; 2023 Feb; 15(1):43. PubMed ID: 36855049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction.
    Düzel E; Ziegler G; Berron D; Maass A; Schütze H; Cardenas-Blanco A; Glanz W; Metzger C; Dobisch L; Reuter M; Spottke A; Brosseron F; Fliessbach K; Heneka MT; Laske C; Peters O; Priller J; Spruth EJ; Ramirez A; Speck O; Schneider A; Teipel S; Kilimann I; Jens W; Schott BH; Preis L; Gref D; Maier F; Munk MH; Roy N; Ballarini T; Yakupov R; Haynes JD; Dechent P; Scheffler K; Wagner M; Jessen F
    Brain; 2022 May; 145(4):1473-1485. PubMed ID: 35352105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.